| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.04 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | -0.094 | 0.04 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.093 | 0.04 |
| mRNA | GDC-0941 | FIMM | pan-cancer | AAC | 0.53 | 0.04 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | -0.089 | 0.04 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.33 | 0.04 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.087 | 0.04 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.084 | 0.04 |